Primary Progressive Multiple Sclerosis research hub
3 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS)
This study is testing a new medicine, SAR442168, for people with Primary Progressive Multiple Sclerosis (PPMS). It's comparing the new medicine to a dummy pill to see if it can slow down the disease's progress and if it's safe to use.
Belgium · France · Austria - recruitingPHASE1
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
This study is investigating a new drug called ixazomib to see if it's safe and helpful for people with different types of multiple sclerosis (MS). We want to find out if it can reduce certain markers in the fluid around the brain and spinal cord.
United Kingdom - ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
Randomized, Single-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Melatonin Administration in Patients With Multiple Progressive Primary Sclerosis (MELATOMS)
This study is looking at how safe and effective melatonin, a natural sleep hormone, might be for people with a type of multiple sclerosis called Primary Progressive MS. Researchers want to see if it can slow down how the disease progresses.
Spain